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ABSTRACT
DNA single-strand breaks containing 3’-blocking
groups are generated from attack of the sugar back-
bone by reactive oxygen species or after base exci-
sion by DNA glycosylase/apurinic/apyrimidinic (AP)
lyases. In human cells, APE1 excises sugar frag-
ments that block the 3’-ends thus facilitating DNA
repair synthesis. In Leishmania major, the causal
agent of leishmaniasis, the APE1 homolog is the
class II AP endonuclease LMAP. Expression of
LMAP but not of APE1 reverts the hypersensitivity
of a xth nfo repair-deficient Escherichia coli strain to
the oxidative compound hydrogen peroxide (H2O2).
To identify the residues specifically involved in the
repair of oxidative DNA damage, we generated
random mutations in the ape1 gene and selected
those variants that conferred protection against
H2O2. Among the resistant clones, we isolated a
mutant in the nuclease domain of APE1 (D70A)
with an increased capacity to remove 3’-blocking
ends in vitro. D70 of APE1 aligns with A138 of
LMAP and mutation of the latter to aspartate signif-
icantly reduces its 3’-phosphodiesterase activity.
Kinetic analysis shows a novel role of residue D70
in the excision rate of 3’-blocking ends. The func-
tional and structural differences between the
parasite and human enzymes probably reflect a
divergent molecular evolution of their DNA repair
responses to oxidative damage.
INTRODUCTION
Oxidative DNA damage is induced by ionizing radiation
(1), by reactive oxygen species produced by the aerobic
metabolism (2,3) and by the action of some antitumoral
agents such as neocarzinostatin and bleomycin (4). The
attack of DNA by free radicals gives rise to oxidative
base damage, abasic sites and single-strand breaks con-
taining modiﬁed 30-ends, such as 30-phosphoglycolate
(30-PG) and 30-phosphate (30-P) (5–7). Damaged 30-ends
may also arise as intermediates during base excision
repair (BER), resulting from the cleavage of the apuri-
nic/apyrimidinic (AP) site by bifunctional DNA glyco-
sylases. For instance, human 8-oxoguanine-DNA
glycosylase (OGG1) and the endonuclease III (NTH)
have intrinsic associated b-lyase activity that cleaves the
phosphodiester backbone 30 to the abasic site through a
b-elimination reaction to produce a 30-a, b-unsaturated
aldehyde (30-dRP) (8–10). In contrast, endonuclease
VIII-like (NEIL) glycosylases incise the abasic site by
b,d-elimination generating a 30-P terminus at the DNA
strand break (11). These 30-blocking damages must be
removed prior to DNA repair synthesis. The current
model for excision of 30-damaged ends is initiated by a
30-phosphodiesterase or 30-phosphatase activity that
cleaves the phosphodiester bond at 50 position of the
30-blocking group. The product is a single nucleotide gap
with 30-hydroxyl (30-OH) and 50-phosphate termini. The
repair is then accomplished by the incorporation of one
nucleotide by a DNA polymerase (DNA repair synthesis)
and the covalent sealing of the strand break by a DNA
ligase (DNA sealing) (12).
Cells have diﬀerent ways to handle 30-blocking ends.
Escherichia coli possesses two class II abasic (AP)
endonucleases capable of repairing such strand breaks by
excision of the 30-blocking groups: exonuclease III and
endonuclease IV, encoded by xthA and nfo genes (13–15).
xthA and xthA nfo strains are highly sensitive to hydrogen
peroxide (H2O2) (16), oxidative agent that induces strand
breaks with 30-blocking damages as primary lethal lesion
(17). In human cells, the exonuclease III homolog is AP
endonuclease 1, APE1. In vitro, the human enzyme can
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the removal of the 30-dRP generated after b-elimination
(23–25) although its 30-phosphodiesterase function has
been reported less eﬃcient than its incision activity on
AP sites (19,20,22). In fact, the expression of human AP
endonuclease can replace bacterial exonuclease III at
repairingalkylation-inducedAPsites,butnotatprocessing
the strand breaks generated by oxidative agents (16,26,27).
In spite of this, APE1 has been shown to provide the major
phosphoglycolate removal activity in human cell extracts
(28) although other sources of such activity cannot be ruled
out (18,29–33). APE1 also has DNA 30-phosphatase activ-
ity in vitro, but polynucleotide kinase phosphatase (PNKP)
has been reported as the primary 30-phosphatase activity
responsible for the excision of 30-P lesions in mammalian
cells(25).Inaddition,APE1has30 to50 exonucleaseactivity
(34),whichcouldbephysiologically relevantintheremoval
of mismatched or damaged nucleotides incorporated
during the synthesis step of BER (35,36). Finally, APE1
can also incise DNA at the 50-position of oxidized pyrimi-
dine bases such as 5,6-dihydro-thymine or 5,6-dihydro-
20-deoxyuracil (DHU), thus initiating a repair process
known as nucleotide incision repair (NIR) (37).
Human cells possess a second AP endonuclease of the
exonuclease III family, APE2, which is endowed with
strong 30 to 50 exonuclease and 30-phosphodiesterase activ-
ities but a very low AP endonuclease activity (32). The
presence of these biochemical activities in the puriﬁed
protein suggests an important role in the processing of
30-blocking ends and in the proofreading of 30-mismatched
nucleotides.
Kinetoplastid parasites such as Leishmania are exposed
to a highly oxidative environment within the host macro-
phage. Our previous studies suggest that L. major’s AP
endonuclease LMAP must play an important role in par-
asite survival mediating the repair of apurinic/apyrimidi-
nic sites and 30-blocked termini induced by oxidative stress
since in addition to its function as an AP endonuclease,
LMAP has an equally eﬃcient 30-phosphodiesterase and
a signiﬁcant 30-phosphatase activity (38). In contrast to
human APE1, over-expression of LMAP in E. coli pro-
tects against both methyl methanesulphonate (MMS) and
H2O2 indicating that LMAP eﬃciently repairs the DNA
lesions caused by these two DNA damaging agents
(38,39). Therefore, we were interested in identifying
the speciﬁc residues involved in the recognition and/or
cleavage of 30-blocking ends at single strand breaks by
these two AP endonucleases. Since LMAP has no obvious
structural particularities that may account for such diﬀer-
ent enzymatic behavior, we sought to isolate mutants
with altered repair capacity of this type of lesions. In the
present study, we report the isolation of a mutant in the
nuclease domain of APE1 that protects xth nfo E. coli
strain against H2O2-induced DNA damage and has an
increased 30-phosphodiesterase and 30-phosphatase activ-
ities. The mutation consists in a single base change, lead-
ing to the single amino acid change D70A. The opposed
mutation at the corresponding position in LMAP
(A138D) was then introduced by site-directed mutagenesis
and the complementation phenotypes and enzymatic
properties of these mutants were determined. The study
reveals a novel role for D70 of APE1 in the repair of
damaged 30-ends and discusses its possible implication in
the process of catalysis.
MATERIALS AND METHODS
Expression plasmids
The construction of expression vectors pKK-ape1 and
pKK-LMAP has been previously described (38).
The pKK-LMAP
A138D mutant plasmid was constructed
by using the QuickChange mutagenesis kit (Stratagene)
with the primers 50-cat tac gtg gaa cgt cga cgg cct acg
cgg g-30 and 50-ccc gcg tag gcc gtc gac gtt cca cgt aat
g-30 on the plasmid template pKK-LMAP. For the con-
venience of subsequent identiﬁcation, these primers
also contain a silent change that results in a novel SalI
restriction enzyme site (underlined). Plasmids pKK223-3,
pKK-LMAP, pKK-ape1 and pKK-LMAP
A138D were
transformed into BW528 strain (nfo-1::Kan  (xth-
pncA)) for subsequent complementation studies.
For protein expression purposes, APE1
D70A was par-
tially digested with NdeI and HindIII from pKK-
APE1
D70A and a band corresponding to full-length
APE1
D70A was cloned into pET28a, previously digested
with NdeI and HindIII. pET28-LMAP
A138D was gener-
ated by using QuickChange mutagenesis kit (Stratagene)
with primers 50-cat tac gtg gaa cgt cga cgg cct acg cgg g-30
and 50-ccc gcg tag gcc gtc gac gtt cca cgt aat g-30 on the
plasmid template pET28a-LMAP.
To produce pX63-LMAP
A138D, LMAP-A138D was
ampliﬁed by PCR from pET28-LMAP
A138D with primers
50-gca gat cta tgg cct cga agc-30 and 50-gca gat ctc atg ggt
gtc gca-30. The PCR product was digested with BglII and
cloned into BglII-digested pX63NEO. A clone with the
correct orientation was chosen after digestion with
EcoRI and DNA sequencing.
Isolation of amutantape1 andlethality assayin E. coli
A random library of ape1 mutants was generated by trans-
forming the mutator strain XL1-Red (Stratagene, La
Jolla, CA, USA) with the prokaryotic ape1 expression
plasmid, pKK-ape1, according to manufacturer’s proto-
col. Cells were transformed with 40ng of pKK-ape1,
plated on Luria-Bertani (LB) agar with ampicillin (Amp)
and incubated overnight at 378C. Next day, approxi-
mately 200 colonies were scraped and washed oﬀ the
agar with LB and transferred to 10ml LB+Amp and
grown for 24h. Subsequently, this culture was diluted
1:10000 and grown for an additional 24h before plasmid
puriﬁcation.
An overnight culture of strain BW528 harboring the
mutagenized plasmid library was diluted 100-fold in
LB+Amp and incubated at 378C until it reached an opti-
cal density of 0.8 at 600nm. The culture was then spun
down, washed and resuspended in phosphate-buﬀered
saline (PBS). Cells suspension was exposed to 1mM
H2O2 for 30min at 378C, diluted 100-fold and incubated
in liquid LB+Amp at 378C overnight. Next day, cells
were exposed to 5mM H2O2 following standard lethality
assay conditions and plated on LB+Amp. Plasmid DNA
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tive media and was used to re-transform BW528, to con-
ﬁrm the H2O2-resistant phenotype. Additionally, ape1
gene from individual clones was cutoﬀ with EcoRI and
HindIII, cloned into pKK223-3 and the plasmid used to
transform BW528 to check for complementation follow-
ing H2O2 treatment. The nucleotide sequence of the entire
ape1 gene of the mutagenized pKK-ape1 plasmids was
determined and one such mutant with a missense mutation
in ape1 resulting in the substitution of aspartate for ala-
nine at residue 70 was chosen for further study.
Survival curves were obtained by exposing approxi-
mately 10
8 cells from exponentially growing cultures to a
range of drug concentrations for 30min at 378Ci nL B
medium. Serial dilutions were made in PBS prior to plat-
ing on LB agar with ampicillin. Colonies were counted
after incubation at 378C for 24h.
Substrates, enzymes andantibodies
The 21-mer oligonucleotides containing a tetrahydrofura-
nyl residue (THF) (50-cct gcc ctg [THF]gc agc tgt ggg) and
an abasic site (AP) (50-cct gcc ctg [AP]gc agc tgt ggg) were
from Trevigen (Gaithersburg, MD, USA). The oligonu-
cleotides harboring a 30-PG residue (50-cct gcc ctg-
30[PG]), a 50-phosphate (50[P]-gc agc tgt ggg-30) and the
oligonucleotide containing a DHU residue (50-cct gcc ctg
[DHU]gc agc tgt ggg) were synthesized by Eurogentec
(Lie ` ge, Belgium). The rest of oligonucleotides were syn-
thesized at the Analytical Services of IPBLN (Granada,
Spain), including the exonuclease substrates 50-cctgccctgT
and 50-cctgccctgC. Oligonucleotides were labeled at the
50-end using [g-
32P]ATP (3000Ci/mmol; GE Healthcare)
and T4 polynucleotide kinase (Promega). The
32P-labeled
oligonucleotides were puriﬁed using MicroSpin G25 col-
umns (GE Healthcare) and annealed to 1.5-fold molar
excess of the complementary strand by incubating at
958C for 2min, followed by slow cooling to room tem-
perature. THF was annealed to a complementary oligonu-
cleotide containing A opposite the lesion (CompA); 30-PG
was annealed to CompA and 50-P to produce a strand
break; DHU was annealed to a complementary oligonu-
cleotide with G opposite the base lesion CompG; C and T
exonuclease substrates were annealed to CompG and 50-P.
For the preparation of a nicked DNA with a 30-dRP res-
idue or a 30-P, the AP site-containing duplex was treated
with an excess of E. coli endonuclease III (Trevigen) or
Fpg (kindly provided by Dr Boiteux), respectively for 1h
at 378C. The reaction mixture was treated with proteinase
K for 30min at 378C and extracted with a phenol–chloro-
form mixture and the DNA was precipitated from the
aqueous phase by ethanol precipitation. After drying,
the DNA was resuspended in H2O and re-hybridized.
Histidine-tagged AP endonucleases were puriﬁed on
Ni
2+-charged HiTrap Chelating HP columns (Amersham
Biosciences) as previously described (38). The eluates were
concentrated and applied to a Superdex-75 gel ﬁltration
column (Amersham Biosciences). The His-APE1 and
His-LMAP fusion proteins were eluted in phosphate
buﬀer (50mM sodium phosphate, pH 7.0, 150mM NaCl
and 10mM 2-mercaptoethanol), aliquoted and stored in
20% glycerol at  808C. Protein concentration was deter-
mined using NanoDrop ND-1000 Spectrophotometer.
Polyclonal rabbit antiserum raised against the recombi-
nant LMAP was generated as previously described (39).
The antiserum was puriﬁed by chromatography in a
protein A-sepharose column (Sigma) according to the
manufacturer’s instructions. Rabbit anti-human APE1
antiserum was purchased from Alpha Diagnostic
(San Antonio, TX, USA). An antibody directed towards
L. major mevalonate kinase was used as protein loading
control (our laboratory stocks).
Enzyme assays and kineticanalysis
In a standard reaction (10ml ﬁnal volume), the corre-
sponding
32P-labeled duplex DNA was incubated in reac-
tion buﬀer [20mM Tris–HCl pH 8.0, 5mM MgCl2,
100mM NaCl, 1% bovine serum albumin (BSA)] with
increasing amounts of AP endonuclease or protein from
whole cell extract as indicated in the ﬁgures. The NIR
activity was assayed in a speciﬁc buﬀer previously
described with minor variations (20mM HEPES–KOH
pH 6.8, 25mM KCl, 0.5mM MgCl2, 1mM DTT and
1% BSA) (37). Reactions were carried out at 378C for
10min and stopped by adding 5ml of formamide dye, fol-
lowed by heating for 5min at 958C before loading in the
gels. When any of these parameters was changed it is indi-
cated in the ﬁgure legend. The products of the reactions
were resolved by denaturing 20% polyacrylamide gel elec-
trophoresis (PAGE) (19:1 acrylamide:bisacrylamide). Gels
were scanned and band intensities quantiﬁed using a
Storm PhosphorImager and ImageQuant 5.2 software
(Molecular Dynamics).
Kinetic analysis was performed using the enzymatic
assays described above with variations. Brieﬂy, initial
rates of 30-PG excision were determined by incubating
various enzyme concentrations of APE1 (1–5nM),
LMAP (0.1–1nM), LMAP
A138D (1–5nM) or APE1
D70A
(0.1–1nM) with increasing concentrations (31–2000nM)
of the 50-
32P-labeled 30-PG-containing duplex for 150s
at 378C under standard reaction conditions. AP site
incision initial rates were determined by incubating
APE1 (0.1–0.5nM), LMAP (0.1–0.5nM), LMAP
A138D
(1–5nM) or APE1
D70A (1–5nM) with increasing concen-
trations (31–500nM) of the 50-
32P-labeled THF-contain-
ing duplex for 150s at 378C. In all cases, at least ﬁve
independent data points from three independent experi-
ments were used. By determining the initial rates (V) at
each substrate concentration [S], a plot of substrate con-
centration against reaction rate was produced. Kinetic
parameters were estimated by utilizing the software
SigmaPlot 2002 for Windows version 8.0. The Km and
kcat values were determined from nonlinear hyperbolic
ﬁts and used to calculate the eﬃciency of 30-PG excision
and AP site incision (kcat/Km).
Parasites and transfection
Clone P2 of L. major 252line was a gift from Dr Stephen
M. Beverley (Washington University). Promastigote
forms were grown at 288C in M199 medium (Gibco,
Invitrogen) supplemented with 10% heat-inactivated
Nucleic Acids Research,2009, Vol.37, No. 6 1831fetal bovine serum. Parasites were maintained by sequen-
tial passages in vitro. Transfection of L. major was per-
formed essentially as described (40). Logarithmic-phase
promastigotes were transfected by electroporation with
50mg of plasmid DNA. Clones were obtained by plating
on M199 semisolid medium supplements containing
0.032mg/ml of geneticine (G418, Gibco, Invitrogen). All
experiments using transfected cells were carried out in the
presence of 0.032mg/ml G418.
Viability ofLeishmania upon exposure toH2O2
andmethyl methanesulphonate
Mid log-phase transfected cells at 10
7ml
 1 in M199
medium (Gibco, Invitrogen) supplemented with 10%
fetal bovine serum (Gibco, Invitrogen) containing
0.032mg/ml of geneticine (G418, Gibco Invitrogen) were
exposed to increasing concentrations of H2O2 (Merck) or
MMS (Merck) for 1h at 288C. After exposure to the
genotoxic agent, cells were centrifuged, washed and resus-
pended in the same volume of PBS buﬀer. Cells were then
inoculated into 96-well ﬂat bottomed microtiter plates
(Nunc, Denmark) at a density of 10
6cells/100ml. Wells
without cells served as control. Twenty microlitres of
Resazurin (1.1mg/ml, Sigma) were added to each well
and incubated in the dark for 1h at 288C. After the incu-
bation period, the reaction was stopped by adding 50mlo f
3% Sodium Dodecyl Sulfate (SDS). Cell viability was esti-
mated by measuring the ﬂuorescence at 570nm excitation
wavelength and 590nm emission wavelength in a
SpectraMax GEMINI EM microplate reader (Molecular
Devices, Sunnyvale, CA, USA). Experiments for each
compound were performed three times, in duplicate.
Standard curves were obtained after serial dilution
of Leishmania cells in 100ml of PBS and measurement of
the ﬂuorescence after 1h of incubation with 20mlo f
Resazurin.
RESULTS
Genetic selection ofamutant APE1protein that confers
resistanceto H2O2in E. coli
Having previously shown that APE1 and LMAP diﬀer in
their ability to protect E. coli against oxidative agents such
as H2O2 (38), we were interested in gaining insight into the
structural determinants that might account for these dif-
ferent properties. Since the respective catalytic domains
contain no readily identiﬁable motifs that could be easily
targeted for mutagenesis, a strategy was devised based on
the genetic selection of ape1 mutants that had gained the
ability to restore the resistance to oxidative damage of
the E. coli strain BW528 (xth nfo), which is deﬁcient in
the major AP endonucleases, exonuclease III and endonu-
clease IV (41). It can be hypothesized that one such
mutant would have an enhanced capability to process oxi-
dative damage by excising the 30-blocking groups gener-
ated at DNA single-strand breaks. To identify such
mutants, the E. coli expression plasmid expressing full-
length ape1 was randomly mutagenized and selected for
colonies that survive after serial treatments with H2O2.
Several clones were isolated and sequenced. One carrying
a single base mutation (A209!C) that leads to a D70A
substitution in APE1 was chosen for further study. Only
another base substitution was identiﬁed in other clones
consisting in the transition mutation A209!G that gener-
ates a related amino acid change (D70G).
The primary sequence alignment of APE1 with other
AP endonucleases from diﬀerent species shows that D70
is located in a highly conserved motif (Figure 1A). This
residue appears to be restricted to mammalian enzymes
since other eukaryotic and prokaryotic sequences have
alanine or asparagine at the same position. An exception
is human APE2 that, together with yeast APN2, presents
an asparagine instead of an aspartate. Interestingly, in the
AP endonuclease LMAP from L. major, D70 is substi-
tuted by an alanine at residue 138. We therefore set out
to make the mutant A138D of LMAP in order to conﬁrm
the role of this amino acid in oxidative DNA damage
processing. Thus, APE1
D70A and LMAP
A138D were
expressed in the BW528 strain to carry out lethality
assays with H2O2 and MMS. Figure 1B shows the western
blot analysis of the level of expression of the four proteins
in BW528 at the conditions used in the lethality assays.
In agreement with the selection strategy used in the isola-
tion of the APE1
D70A mutant that was speciﬁcally aimed
at identifying the residues involved in H2O2-induced
damage repair, indeed the expression of APE1
D70A
mutant signiﬁcantly increased the survival of the repair-
deﬁcient strain treated with H2O2. In contrast, cells
expressing either APE1 or LMAP
A138D were equally sen-
sitive to the oxidative agent and exhibited a behavior sim-
ilar to the xth nfo deﬁcient background (Figure 1C).
To evaluate the eﬀect of the mutations on the repair of
cellular AP sites, the resistance of the diﬀerent strains to
the killing eﬀect of the alkylating agent MMS was deter-
mined (Figure 1D). The sensitivity of BW528 expressing
either APE1 or APE1
D70A was similar as previously
shown for the mutant APE1
D70N (42). Likewise, the
expression of LMAP and LMAP
A138D reverted the sensi-
tivity of strain BW528 to MMS. These results suggest that,
at least in E. coli, residues D70 and A138 have a major
role in the removal of DNA 30-blocking lesions generated
by oxidative attack while their participation in the proces-
sing of AP sites is less critical.
Effect of mutationsD70A andA138D on theremoval of
3’-blocking termini
To establish the eﬀect of mutations D70A and A138D
on the enzyme activities, we ﬁrst compared the
30-phosphodiesterase activity of wild-type and mutant
enzymes in a standard cleavage assay using nicked DNA
with a 30-PG residue as substrate (Figure 2A). There are
disagreeing reports about the electrophoretic behaviour of
a PG-containing oligonucleotide respect to the corre-
sponding 30-OH product. In our hands, the electrophoretic
mobility of the 9-mer product was higher than the corre-
sponding 9-mer with the phosphoglycolate group, an
observation shared by others (28). Upon incubation at
378C, 5nM of puriﬁed APE1
D70A or LMAP proteins
removed most of the 30-PG residues in 10min while the
same enzyme amounts of APE1 or the LMAP
A138D
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tively, of the substrate into the corresponding 30-OH
form. In a time course experiment, the 30-PG excision
activity was analyzed over time intervals during 15min
(Figure 2B). For all four reactions, the product formation
was linear over the time points monitored. In agreement
with the previous assay, the speciﬁc activity was signiﬁ-
cantly increased in the case of the D70A mutant enzyme,
whereas the mutation A138D produced a decrease in
30-PG excision activity.
In order to quantify the extent by which the mutations
aﬀect the catalytic activity of APE1 and LMAP enzymes,
the changes in steady-state kinetic parameters were deter-
mined for the excision of 30-PG from the nicked DNA
duplex substrate used in standard assays described earlier.
The kinetics of excision was determined as a function of
30-PG substrate concentration under steady-state condi-
tions (Figure 2C and D). An estimation of the kcat/Km
ratio revealed that the APE1
D70A mutant was 7-fold
more eﬃcient as a 30-phosphodiesterase than APE1 and
in the same manner, LMAP catalyzes the excision of the
30-PG moiety at a rate over 5-fold higher than the
LMAP
A138D mutant. In addition, the data indicate that
LMAP removes 30-PG ends approximately 6-fold more
eﬃciently than wild-type APE1. The diﬀerences in cataly-
tic activity arise primarily from evident changes in kcat
values, while the Km for the 30-PG substrate remains
unaltered.
Similar diﬀerences were also found for the 30-phos-
phodiesterase activity measured on a 30-dRP substrate
(38). Damaged 30-ends consisting in a nicked DNA with
a3 0-dRP residue can arise in the course of BER repair
by the action of bifunctional DNA glycosylases such
as NTH and OGG1, which are endowed with AP lyase
activity and catalyze a b-elimination reaction. Figure 3A
shows that the enzymes lacking the aspartate at position 70
Figure 1. Identiﬁcation of an amino acid residue in the AP endonucleases APE1 and LMAP critical for the resistance to H2O2 in E. coli.
(A) Sequence alignment of the APE1 amino acid motif that includes D70 with other AP endonucleases of the exonuclease III family. (B)A P
endonuclease protein levels in 2mg of protein cell extracts from each strain were determined by western blotting. (C and D) Sensitivity assay of xth
nfo E. coli strains following treatment with DNA damaging agents. Escherichia coli strains: BW528/pKK223-3 (cross); BW528/pKK223-LMAP (ﬁlled
square); BW528/pKK223-LMAP
A138D (open square); BW528/pKK223-APE1 (ﬁlled circle); and BW528/pKK223-APE1
D70A (open circle). A total of
10
8 cells from exponentially growing cultures were exposed to a range of (C)H 2O2 or (D) MMS concentrations for 30min at 378C in LB medium.
All points are the mean of at least three independent experiments.
Nucleic Acids Research,2009, Vol.37, No. 6 1833(APE1
D70A) or 138 (LMAP) have a higher 30-phospho-
diesterase activity also on this type of lesion. Relatively
low amounts (0.5nM) of APE1
D70A or LMAP catalyze
the excision of all of the 30-dRP substrate used in the
assay. For APE1 and LMAP
A138D, the complete excision
of the fragmented 30-phosphoribose residues requires an
enzyme concentration ﬁve times higher.
When the repair of a modiﬁed base is initiated by a
NEIL glycosylase, a possible DNA product is a gap
with a 30-P. This toxic intermediate can also be processed
by an AP endonuclease, although the 30-phosphatase
activity of APE1 is relatively ineﬃcient (25). We therefore
investigated whether the mutations in APE1 and LMAP
also altered their 30-phosphatase activity. To this end, the
puriﬁed proteins were incubated with a
32P-labeled 21-mer
oligonucleotide duplex carrying a central single-strand
break with a 30-P end and the activity was examined by
the substrate conversion into a moiety with lower electro-
phoretic mobility that corresponds to the 30-OH product
(Figure 3B). The activity assay showed that mutation
D70A in APE1 stimulates the excision of the 30-P from
single-strand breaks. The mutation A138D in LMAP had
the opposite eﬀect and reduced the 30-phosphatase activ-
ity. Taken together, these results indicate that APE1
D70A
Figure 2. Mutations D70A in APE1 and A138D in LMAP aﬀect the excision of 30-PG. (A) The 30-phosphodiesterase activity of APE1, APE1
D70A
(upper gel) LMAP and LMAP
A138D (lower gel) was tested on 21-mer DNA duplex containing a nick with a 30-PG residue and labeled at the 50 of the
lesion-carrying strand. Increasing amounts of the AP endonucleases (0–10nM) were incubated for 10min at 378C with the oligonucleotide substrate
(500nM) under standard reaction conditions. The products of the reactions were separated by denaturing 20% PAGE. Positions in the gel of the
30-PG substrate and the 30-OH product of the reaction are indicated with arrows. (B) Time course assay. Excision of phosphoglycolate was
monitored over a 15-min time course using 500nM of 30-PG substrate and 1nM of enzyme at 378C in standard buﬀer. The reactions were performed
and terminated as described in the Materials and Methods section. The amount of product was quantiﬁed and plotted for time points between 0min
and 15min. Experiments were performed in triplicate. (C and D) Kinetic parameters for the 30-phosphodiesterase activity of (C) APE1 (ﬁlled circle),
APE1
D70A (open circle), (D) LMAP (ﬁlled square) and LMAP
A138D (open square) enzymes. The kcat and Km values represent the average from three
independent determinations. Standard deviations did not exceed 20% for any of the values calculated.
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ferent types of 30-damaged ends. Conversely, the mutation
A138D impairs the ability of LMAP to excise 30-blocking
termini.
Study ofthe 3’ to 5’exonuclease and nucleotide incision
activities of wild-type and mutantAP endonucleases
Oxidized nucleotides such as 8-oxodGTP can be misincor-
porated during the BER process, giving rise to 30-blocking
ends that inhibit the subsequent DNA ligation step. APE1
is the major exonuclease activity in human cells that
excises 30-8oxoG (36) and removes mismatched nucleo-
tides within a single-strand break. We were therefore inter-
ested in ﬁnding out how the mutations generated aﬀected
the exonuclease function and to this end we determined
the excision of dTMP from a T/G mismatch and dCMP
from a C/G correct base pair (Figure 4A). The change of
aspartate for alanine in APE1 substantially enhanced the
removal of the mismatched nucleotide but also increased,
although to a lesser extent, the excision of correctly paired
nucleotide. On the other hand, mutation A138D in LMAP
decreased the excision of both dTMP and dCMP sub-
strates. It is therefore probable that APE1’s exonuclease
also participates in the repair of lethal DNA damages
generated by misincorporation of oxidized nucleotides to
the DNA.
In addition to the exonuclease function, human APE1 is
endowed with another enzymatic activity potentially rele-
vant for the protection against oxidative damage. The
human enzyme has been reported to initiate the repair
of oxidized bases through the incision of the DNA
strand at 50 of the damaged base (37). The NIR activity
of APE1 provides an alternative and complementary
repair pathway to BER. The NIR activity was examined
by monitoring the incision of a DHU-containing oligonu-
cleotide substrate (21-mer) under reaction conditions
previously described by Gros et al. (Figure 4B). In com-
parison to other activities tested, the incision activity was
not signiﬁcantly modiﬁed in the presence or absence of an
aspartate in human and leishmanial AP endonucleases
suggesting that repair of oxidative base damage induced
within DNA has a minor inﬂuence in the protection con-
ferred by APE1
D70A or LMAP. The experiments were
carried out in a speciﬁc NIR reaction buﬀer that diﬀers
from the AP endonuclease/30-phosphodiesterase buﬀer
essentially in pH and magnesium concentration. When
the reactions were performed using this second buﬀer,
less incision product (9-mer) was detected (data not
shown).
Mutations D70Aand A138D decreasethe AP
incision activity
Mutagenesis studies have shown that APE1 mutants at
residue D70 display lower AP endonuclease-speciﬁc activ-
ity than the wild-type enzyme (43,44). To determine the
eﬀect of the A138D mutation on the incision of AP sites
by LMAP, initial reaction rates were measured by incu-
bating the enzymes with increasing concentrations of 21-nt
duplex DNA substrate containing a THF residue. In
agreement with the above-mentioned studies, we found
that wild-type APE1 cleaves AP sites more eﬃciently
than D70A mutant with a kcat value for the incision of
an AP site aproximately 10-fold higher (202 versus
17min
 1) (Figure 5A). No gain of incision activity was
observed mutating LMAP to LMAP
A138D as might have
been expected (Figure 5B). Instead, the mutation pro-
duced a 3-fold decrease in the kcat value with apparently
no eﬀect on the Km, indicating that D138 in LMAP cannot
exert the same function as D70 in APE1. Even though the
human and parasite AP endonucleases have structurally
similar active sites, subtle diﬀerences must exist that aﬀect
the processing of AP sites by the two enzymes.
Effectof Mg
2+ concentration on theenzymatic
activities of APE1and LMAP
Structural and mutagenesis data have led to postulate
the participation of the carboxylate group of D70 in the
coordination of one metal ion during the catalytical
process that leads to AP site cleavage. However, the func-
tion of D70 appears to be restricted to mammalian
AP endonucleases since this amino acid residue is absent
B
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Figure 3. Eﬀect of the amino acid substitutions on the removal of dif-
ferent 30-blocking groups. (A) The 30-phosphodiesterase activity of
APE1, APE1
D70A (upper gel), LMAP and LMAP
A138D (lower gel)
was tested on 21-mer DNA duplex containing a nick with a 30-dRP
residue and labeled at the 50 of the lesion-carrying strand. Increasing
amounts of the AP endonucleases (0–2.5nM) were incubated for 10min
at 378C with the oligonucleotide substrate (5nM) under standard reac-
tion conditions. (B) The 30-phosphatase activity was tested on a
32P-labeled 21-mer DNA duplex containing a nick with a 30-P residue
produced as described in Materials and Methods section. Two concen-
trations of enzyme (1nM and 2nM) were incubated 10min at 378C
with the double-stranded oligonucleotide substrate (5nM) under stan-
dard reaction conditions. The products of the reactions were separated
by denaturing 20% PAGE. Positions in the gel of the substrates and
the 30-OH product of the reaction are indicated with arrows.
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enzymes. To investigate the role of D70 in metal ion
coordination, we compared the activities of APE1,
LMAP and their respective mutant forms over a range
of Mg
2+ concentrations. Irrespectively of the concentra-
tion tested, APE1
D70A and LMAP showed higher 30-phos-
phodiesterase activity than APE1 and LMAP
A138D
(Figure 6A and B, left). In agreement with previous
studies, APE1 (and LMAP
A138D) reached a maximum of
30-PG excision activity at Mg
2+ concentrations around
2.5mM, the excision being severely inhibited (below
25%) at 10mM and higher ion concentrations
(Figure 6A and B, right) (45,46). In contrast, APE1
D70A
and LMAP exhibited a diﬀerent pattern of inhibition by
magnesium. Both enzymes reached maximum activity
at higher metal concentrations and were more
refractory to Mg
2+ inhibition, thus still retaining about
50% of activity at 20mM (Figure 6A and B). These results
conﬁrm that amino acid changes D70A in APE1 and
A138D in LMAP have opposing eﬀects on the 30-phos-
phodiesterase activity and show that the residue D70 has
an important role in magnesium-mediated inhibition.
Thus, when a certain metal concentration is reached,
D70 may bind to Mg
2+ which results in inhibition of
the enzyme activity.
To investigate whether the D70A mutation also altered
Mg
2+ inhibition using a diﬀerent substrate, the AP
endonuclease activity was measured on a THF-containing
oligonucleotide at a variety of magnesium concentrations.
Under the conditions assayed, APE1 exhibited the highest
activity at 5mM of metal while the speciﬁc activity of
APE1
D70A did not reach a maximum until 40mM of
Mg
2+ was added to the reaction (Figure 6C). Inhibition
was not evidenced until 80mM was reached (data
not shown). For the parasite enzymes LMAP and
LMAP
A138D, the activity peaks were also obtained at
diﬀerent magnesium concentrations (10 and 2.5mM,
respectively) (Figure 6D). For both enzymes containing
B
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Figure 4. Exonuclease and NIR activities. (A) The 30 to 50 exonuclease activity of APE1, APE1
D70A, LMAP and LMAP
A138D was tested on a
32P-labeled 21-mer DNA duplex containing a nick with a 30-T/G mismatch (T/G) (upper gels) or a 30-C/G correct pair (C/G) and a phosphate group
at 50. Increasing amounts of the AP endonucleases (0–10nM) were incubated for 10min at 378C with the oligonucleotide substrate (5nM) under
standard reaction conditions. (B) The NIR activity was tested on a
32P-labeled 21-mer DNA duplex containing a DHU residue. The enzymes
(0–10nM) were incubated for 10min at 378C with the double-stranded oligonucleotide substrate (5nM) under speciﬁc NIR reaction conditions
described in Materials and Methods section. The products of the reactions were separated by denaturing 20% PAGE. A 9-mer oligonucleotide was
loaded as migration control (C) for the NIR product. Positions in the gel of the substrates and the 30-OH product of the reaction are indicated with
arrows.
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lower metal concentrations. However, it should be noted
that at optimal metal concentrations, both mutant
enzymes have lower AP endonuclease activities than the
respective wild-type proteins.
Over-expression ofLMAP
A138D sensitizes Leishmania
cellsto oxidative agents
The biochemical analysis of the mutants described in this
work evidences subtle but signiﬁcant diﬀerences between
the parasite and human AP endonucleases that could
Figure 6. Comparison of the activities of wild-type and mutant AP endonucleases at diﬀerent magnesium concentrations. (A and B) The
30-phosphodiesterase and (C and D) AP endonuclease activity assays were carried out in standard buﬀer with increasing Mg
2+ concentrations
(1–40mM) by incubating the enzymes with 500nM of the 30-PG or THF substrate, respectively. Speciﬁc activities (left) and relative activities (right)
are represented for each of the enzymes. Relative activities were calculated assigning a value of 100% to the maximal activity reached for an enzyme
at a given Mg
2+ concentration. To monitor the excision of phosphoglycolate and AP site incision in the absence of magnesium in the reaction
mixture, a reaction with 20mM EDTA was included. Enzymes are represented with the following symbols: APE1 (ﬁlled circle), APE1
D70A (open
circle), LMAP (ﬁlled square) and LMAP
A138D (open square). Units are deﬁned as picomoles of reaction product generated per minute at 378C.
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Figure 5. Michaelis–Menten plots for the calculation of the Km and Vmax values of the AP endonuclease activity. (A) APE1 (ﬁlled circle), APE1
D70A
(open circle); (B) LMAP (ﬁlled square), LMAP
A138D (open square). The kcat and Km values represent the average from three independent determina-
tions. Standard deviations did not exceed 20% for any of the values calculated.
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repair. To further examine the role of residue A138 of the
LMAP enzyme in parasite survival under genotoxic stress,
the mutant enzyme LMAP
A138D was over-expressed in
L. major cells. A cell line over-expressing LMAP
A138D
(pX-138) was generated by transfection with the expres-
sion vector pX63Neo-LMAP
A138D and selection of clones
resistant to G418 at 32mg/ml. Cell lines over-expressing
LMAP wild-type (pX-LMAP) and a control cell line (pX)
harboring the empty expression vector have been obtained
and described elsewhere (47). The level of expression of
the selected clones was determined by western blot using a
puriﬁed antibody directed against pure recombinant
LMAP (Figure 7A). Protein quantity standardization
was carried out using an antibody directed against L.
major mevalonate kinase (MVK). Cell lines pX-LMAP
and pX-138 expressed 9- and 16-fold higher levels of
LMAP, respectively, than cell line pX. It was also checked
that growth rate was not aﬀected by the protein over-
expression.
The cellular localization of the expressed proteins was
determined by immunoﬂuorescence microscopy using the
puriﬁed antibody mentioned above. As shown in
Figure 7B, LMAP and the mutant LMAP form were
both clearly located in the nucleus. Constitutive endogen-
ous expression levels of LMAP are signiﬁcantly lower than
Figure 7. Sensitivity of Leishmania cells to H2O2 and MMS-induced DNA damages. (A) Western blot showing LMAP protein levels in whole cell
extracts from 2.5   10
6 parasites harboring vector pX63-Neo (cell line pX), expressing wild-type LMAP (cell line pX-LMAP) or LMAP
A138D (cell
line pX-138). As control of charge, level of mevalonate kinase protein was measured in the three cell lines. (B) Immunoﬂuorescence analysis was
performed to establish the intracellular localization of LMAP in L. major cell lines pX, pX-LMAP and pX138. Nuclear and kinetoplast DNA were
stained with DAPI and LMAP and LMAP
A138D were detected with anti-LmAP and FITC conjugated anti-rabbit secondary antibody. Images were
collected with a Zeiss Axiophot microscope. (C) The 30-phosphodiesterase and (D) AP endonuclease activities of whole cell extracts from cell lines
pX, pX-LMAP and pX-138 were tested on 21-mer DNA duplex containing a nick with a 30-PG residue or a THF residue, respectively, and labeled at
the 50 of the lesion-carrying strand. Increasing amounts of protein (0–100ng) were incubated for 30min at 378C with the oligonucleotide substrate
(2000nM) under standard reaction conditions. The products of the reactions were separated by denaturing 20% PAGE. (E) A total of 10
7cells/ml
from mid-log phase Leishmania cultures were exposed to increasing concentrations of H2O2 (left) or MMS (right) concentrations for 1h at 288Ci n
M199 medium supplemented with 10% fetal bovine serum. After exposure to the genotoxic agent, cells were centrifuged, washed, resuspended in the
same volume of PBS buﬀer and incubated with resazurin for 1h at 288C. Fluorescence was measured at 570nm excitation wavelength and 590nm
emission wavelength. Experiments for each compound were performed three times, in duplicate.
1838 Nucleic Acids Research, 2009, Vol. 37,No. 6those obtained in over-expressing parasites. In mamma-
lian cells, diﬀerent forms of APE1 have been localized in
the nucleus and mitochondria (48,49). Even in cells that
over-express the protein, no LMAP appeared to be asso-
ciated with the mitochondrion or kinetoplast. However,
we cannot rule out the possibility that a minor fraction
is present in this organelle.
To further characterize the constructed cell lines, whole
cell extracts were assayed for cleavage activity using a
DNA substrate harboring a nick with a 30-PG end or
an AP site analog (Figure 7C and D, respectively).
The expression of the LMAP wild-type protein in the
selected clone was associated with at least a 5- and
8-fold increase in the 30-PG excision and AP site-
cleavage activity levels, respectively. In contrast, the
over-expression of LMAP
A138D in cell line pX-138
reduced the level of 30-phosphodiesterase around 5-fold
respect to the endogenous activity of cell line pX
(according to the product formed at 100ng of protein
extract) while surprisingly, the level of AP site incision
remained similar. It should be taken into consideration
that repair activities of recombinant proteins may not
necessarily reﬂect eﬀective cellular repair since factors
that modulate incision activities may be absent in the
in vitro assay.
In an earlier study it was demonstrated that para-
sites overproducing LMAP have an enhanced resistance
to H2O2 (47). Here, we compared the viability of cell lines
overproducing either wild-type LMAP or LMAP
A138D in
the presence of the DNA damaging agents H2O2 and
methyl methanesulphonate. Figure 7E (left) shows the
eﬀect on cell survival after 1-h exposure to increasing con-
centrations of H2O2. Following treatment with 0.5mM
H2O2, the number of viable cells expressing LMAP
A138D
is reduced to 50% while the proportion of surviving cells
transfected with the empty vector or over-expressing
LMAP remains 76% and 86%, respectively. Indeed, expo-
sure to 1mM H2O2 has a minor eﬀect on the survival
of cell-line pX-LMAP (80%) but produces a considerable
impact on cell line pX (50%) and even more pronounced
on cell line pX-138 (30%). Therefore, while parasites
expressing LMAP were protected against H2O2, cells
over-expressing LMAP
A138D became even more sensitive
to killing by this oxidative agent than cells transfected
with the empty vector. It can be concluded that residue
A138 plays an important role in the repair of oxidative
DNA damage by LMAP and its substitution by an aspar-
tate has an impact on the viability of cells exposed to
oxidative agents. In contrast, the expression of the
LMAP or LMAP
A138D proteins did not have a signiﬁcant
eﬀect on survival after treatment with MMS, which
alkylates mainly purine bases in DNA and produces AP
sites (50) (Figure 7E, right). Similar results have been
obtained expressing the Ape1 cDNA in CHO cells (51),
suggesting that the constitutive levels of AP-endonuclease
activity in both organisms are suﬃcient to repair the AP
sites generated by alkylating agents. Thus, the lethal eﬀect
observed after MMS treatment is probably due to the
block of DNA replication by the alkylation-induced
DNA adducts such as N
3-methyl adenine.
DISCUSSION
Human APE1 protein has been subjected to an exhaus-
tive search for residues that are critical for cleavage of
DNA at AP sites (43,45,46,52–61). Active site
residues involved in hydrolysis and metal coordination
or AP site binding have been identiﬁed by site-directed
mutagenesis on highly conserved amino acids and
by the analysis of the crystal structure of APE1 bound
to substrate abasic DNA (56). Besides its AP endonu-
clease activity, APE1 can remove some types of
30-blocking lesions at DNA single-strand breaks in vitro,
on account of its 30-phosphodiesterase, 30 to 50 exo-
nuclease and 30-phosphatase activities. However, even if
the diﬀerent nuclease activities of the APE1 protein
appear to share a common active site, the human
enzyme carries out these other types of chemical reactions
at a lower rate than AP site cleavage (19,25,38,62).
It results obvious that some unnoticed structural elements
of the enzyme must modulate substrate speciﬁcity,
although to date, the catalytical determinants for the
hydrolysis of 30-end damaged termini have not been
fully understood. More intriguingly, other AP endonu-
cleases belonging to the same family, such as exonuclease
III and the AP endonuclease from L. major LMAP,
share with APE1 the overall 3D structure and most of
the catalytic groups in their active sites and can catalyze
the removal of damaged nucleotides and phosphate
groups from 30-ends more eﬃciently than APE1
(38,63,64). All the biochemical reactions mentioned,
including AP site cleavage, entail the hydrolysis of a
P–O bond but the substrates diﬀer in size, charge and/
or structure. It is therefore of interest to understand
how similar catalytic sites can account for diﬀerent sub-
strate speciﬁcities.
As shown by protein engineering and in vitro evolution
experiments, single amino acid substitutions can drasti-
cally change substrate speciﬁcity and increase the activity
of any enzyme. In this regard, there are several examples
of how mutations can alter the activity and reaction spe-
ciﬁcity of DNA repair enzymes (65). We have taken
advantage from such functional plasticity and using a
complementation assay in a repair-deﬁcient E. coli
strain, have selected a mutant in the nuclease domain of
the human AP Endonuclease 1 (APE1
D70A) that confers
resistance to H2O2-induced DNA damage. D70 is a poorly
conserved residue located in the middle of a highly con-
served region comprising amino acids 62–78 of the human
protein (Figure 1A). In vitro, the puriﬁed APE1
D70A pro-
tein shows a higher capacity to process diﬀerent types of
30-blocking ends including 30-PG, 30-dRP and 30-P groups.
It also has an enhanced exonuclease activity on mis-
matched 30-nucleotides within single-strand breaks. A
comparative analysis with APE2 has allowed for the iden-
tiﬁcation of F266 and W280 as two residues critical for 30
to 50 DNA exonuclease activity and APE1 mutants with
increased exonuclease activity have been generated (66).
However, these residues do not appear to be responsible
for the increased phosphodiesterase and exonuclease
activities of Leishmania AP endonuclease which exhibits
the same residues as APE1.
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strate speciﬁcity of the enzyme. In agreement, the change
of alanine by an aspartate at the equivalent position in
LMAP clearly decreases the excision of 30-blocking ends
by the parasitic enzyme. A kinetic analysis shows that the
replacement of aspartate by an alanine in APE1 enhances
the rate of cleavage of 30-PG termini without aﬀecting the
Km, which indicates that catalysis or a step following
catalysis is accelerated by the amino acid change.
In other words, the aspartate residue limits somehow
the catalytic turnover of APE1 and LMAP
A138D for
30-damage excision. It is worth noting that this negative
eﬀect is probably due to the charge and not the size of the
aspartate side chain since the catalytically eﬃcient exonu-
clease III and human APE2 have asparagine at the same
position. On the contrary, D138 in LMAP and D70 in
APE1 must play diﬀerent roles during the AP site incision
reaction since both D70A and A138D mutations reduce
the rate of AP site cleavage. It is probable that the para-
sitic enzyme possesses adaptive second site features that
substitute the function carried out by D70 in human APE1
and confer the maximal AP endonuclease activity.
Several structural and biochemical studies have sug-
gested that amino acid D70 contributes to the coordina-
tion of the cationic metal at the active site of APE1
(44,46,54). However, the aspartate is substituted by aspar-
agine or alanine in other AP endonucleases (i.e. exoIII and
LMAP) and its replacement by mutagenesis does not have
a dramatic eﬀect on the incision activity of APE1 (43; this
study). When the speciﬁc activities of wild-type and
mutant enzymes were determined over a range of metal
concentrations, the activity versus magnesium concentra-
tion curves showed two diﬀerent eﬀects of the metal ion as
previously described. Low magnesium concentrations
stimulate catalysis, as this ion is required for the cleavage
reaction, while high metal concentrations result inhibitory
for the activity (52). Furthermore, lower magnesium con-
centrations were required for inhibition of wild-type APE1
than for the mutant D70A. The opposite eﬀect was
observed with LMAP and mutant A138D indicating that
metal ion-mediated inhibition is more pronounced on
those enzymes with aspartate. The inhibition of APE1
activity by high Mg
2+ concentrations has been hypothe-
sized to be due to an oversaturation of the enzyme cata-
lytic site when the two proposed existent metal sites are
occupied simultaneously (67). In this scenario, it can be
hypothesized that at high metal concentrations, aspartate
70 attracts Mg
2+ ions to the active site that interfere
with the catalytic process. A close examination of the
APE1-DNA crystal structure suggests an alternate possi-
bility. The situation of D70 makes possible an interaction
with the DNA strand complementary to the AP site DNA.
Such interaction might distort the DNA and contribute to
the positioning of the substrate in the active site. At inhib-
iting metal concentrations, the ‘extra’ metal ions
recruited by D70 would perturb the interaction and
hence, the substrate alignment at the catalytic site. The
partial loss of AP incision activity of the D70A mutant
might be due at least in part, to a poor substrate orienta-
tion in the active site when the aspartate is absent. It is
tempting to speculate that the interaction between D70
and the DNA strand opposite to the AP site (when D70
is not bound to Mg
2+) favors cleavage of AP sites by
exerting an inﬂuence on the DNA conformation as
described above, but somehow impedes the correct posi-
tioning of the more ‘bendable’ bonds that bear phospho-
glycolates, phosphates or mismatched nucleotides. We are
aware that the available data are not suﬃcient to under-
stand the role of residue D70 during AP site or 30-end
cleavage and further structural and biochemical experi-
mentation will be required to fully establish its function.
Regardless of the possible catalytic mechanism, our
work reveals signiﬁcant diﬀerences in the processing of
30-blocking DNA damages between kinetoplastid para-
sites and humans. The presence of alanine or aspartate
in the AP endonucleases from these two organisms pro-
vides an exceptional perspective on the molecular evolu-
tion of their DNA repair responses to oxidative damage. It
is reasonable to think that genetic changes took place
probably according to the amount and diﬀerent types of
DNA damage they were exposed to. In Leishmania cells,
the eﬃcient functioning of its oxidative damaged DNA
repair pathways is likely critical for survival during the
oxidative burst that takes place in the mammalian host.
In support of this, we have shown that over-expression of
LMAP protects the parasite against high levels of oxida-
tive stress induced by H2O2. Although DNA single-strand
breaks are probably the primary lethal lesion induced by
H2O2, AP site and exonuclease repair activities of APE1
can possibly contribute to this protection. In contrast,
expression of mutant LMAP
A138D protein sensitizes
the cells treated with this oxidative agent. An excess of
mutant enzyme in the cell may block access to the
30-damaged strand breaks of the endogenous LMAP thus
slowing down repair and increasing cell death. Taken
together, our results provide novel structural and func-
tional information that might be exploited in the rational
design of selective inhibitors to treat leishmaniasis.
DNA single-strand breaks are also frequent lesions in
human DNA and their repair of vital importance for
the cell. In vivo, the catalytical deﬁcit of APE1 as 30-phos-
phodiesterase might be compensated by the action of
other factors that activate or complement APE1 function.
For instance, the XRCC1 protein, absent in Leishmania,
has been shown to act as a scaﬀold and modulator of
diﬀerent BER activities. XRCC1 physically interacts
with APE1 and stimulates, at least in vitro, its AP endo-
nuclease and 30-phosphodiesterase activities (68). In addi-
tion, recent studies show that human cells possess other
enzymes with strong 30-phosphodiesterase activities
in vitro like APE2, a second class II AP endonuclease,
and aprataxin, the gene product defective in the neurolog-
ical disorder AOA1 (ataxia oculomotor apraxia-1). These
enzymes might assist APE1 in the repair of 30-PG lesions
(32,33). Thus, human cells have evolved to possess a vari-
ety of DNA repair factors capable to initiate the proces-
sing of DNA single-strand breaks and maintain genome
integrity. Why one of these major factors, APE1, has not
been fully optimized during evolution in terms of reaction
rate is an important question that should be answered in
order to understand its function.
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